Efficacy and safety of commonly used thromboprophylaxis agents following hip and knee arthroplasty
We recommend the use of either aspirin < 325 mg daily, enoxaparin, or dabigatran for VTE prophylaxis following hip and knee arthroplasty.
Authors
- Morgan Berman
- Martin Coia (ORCID: https://orcid.org/0000-0002-1197-1967)
- Job Nicolaas Doornberg (ORCID: https://orcid.org/0000-0002-1270-2742)
- Tim Soon Cheok (ORCID: https://orcid.org/0000-0003-1215-9361)
- Alexander Beveridge (ORCID: https://orcid.org/0000-0003-0951-1053)
- Ruurd Lukas Jaarsma (ORCID: https://orcid.org/0000-0003-4308-7815)
- Alexander Campbell
- T Tse
Institutions
- University Medical Center Groningen (NL)
- Flinders University (AU)
- Middlemore Hospital (NZ)
- Monash Medical Centre (AU)
- Lyell McEwin Hospital (AU)
- Flinders Medical Centre (AU)
- Palmerston North Hospital (NZ)
- Cardiff University (GB)
Publication Details
- Journal
- The Bone & Joint Journal
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1302/0301-620x.106b9.bjj-2023-1252.r2
- Citations
- 11
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.04